Division of Viral Diseases, Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency, Chungcheongbuk-do.
Division of Infectious Disease Diagnosis Control, Honam Regional Centers for Disease Control and Prevention, Korea Diseases Control and Prevention Agency, Gwangju-si, Republic of Korea.
Medicine (Baltimore). 2021 Apr 30;100(17):e25632. doi: 10.1097/MD.0000000000025632.
The 17 Provincial Institutes of Health and Environment (PIHEs) in Korea use HIV antibody, antigen, and Western blot assays for confirmatory testing of HIV infection. The Korea Disease Control and Prevention Agency (KDCA) has further included p24 antigen neutralization and nucleic acid tests (NATs) since 2015. Our study aimed to investigate the effect of this new testing algorithm on the confirmation rate of HIV infection.Annual changes, from 2012 through 2017, in positive or indeterminate HIV confirmatory results were compared for the two algorithms between the PIHEs and the KDCA. Fiebig stages and Western blot p31 band were used to identify the diagnostic proportions of acute or early chronic HIV for the two algorithms.The number of positive cases in the samples requested from PIHEs for reconfirmation by the KDCA has steadily increased from 10.3% in 2014 to 33.3% in 2017. However, the number of indeterminate cases dropped sharply, from 71.9% in 2014 to 14.0% in 2017. The results for the p31 reactive band were 27.4% and 88.4% for the KDCA and PIHEs, respectively. Of positive cases reported by the KDCA, 22.9% were in the early acute stage and Fiebig stages I to II.The new testing algorithm has improved the diagnosis of HIV infections in the early acute stage. Early confirmatory diagnosis can prevent secondary transmission of HIV and provide early treatment opportunities for people living with HIV infection.
韩国的 17 个省级卫生与环境研究所(PIHEs)使用 HIV 抗体、抗原和 Western blot 检测法进行 HIV 感染的确认性检测。自 2015 年起,韩国疾病管理本部(KDCA)进一步纳入了 p24 抗原中和和核酸检测(NATs)。我们的研究旨在探讨这一新的检测算法对 HIV 感染确认率的影响。
在 PIHEs 和 KDCA 之间,比较了这两种算法在 2012 年至 2017 年期间,HIV 阳性或不确定的确认性结果的年度变化。Fiebig 分期和 Western blot p31 带用于确定两种算法的急性或早期慢性 HIV 的诊断比例。
从 2014 年的 10.3%稳步增加到 2017 年的 33.3%,请求 KDCA 重新确认的 PIHEs 样本中的阳性病例数量不断增加。然而,不确定病例的数量急剧下降,从 2014 年的 71.9%下降到 2017 年的 14.0%。KDCA 和 PIHEs 的 p31 反应带结果分别为 27.4%和 88.4%。KDCA 报告的阳性病例中,22.9%处于早期急性阶段和 Fiebig 分期 I 至 II 期。
新的检测算法提高了早期急性 HIV 感染的诊断水平。早期确认诊断可以防止 HIV 的二次传播,并为 HIV 感染者提供早期治疗机会。